Cativa CBD Announces PGA Tour Professional Spokesperson Marc Leishman
(PORTSMOUTH, Virginia, September 11, 2019) Cativa Health ("Cativa CBD"), a science-based cannabidiol (CBD) brand set to revolutionize the wellness and CBD industries, announced today that professional golfer Marc Leishman will act as the brand’s first celebrity spokesperson. Mr. Leishman will collaborate with Cativa CBD on a variety of public relations and marketing activities, including promotions, digital and social media campaigns, and events.
“We are elated to have Marc represent Cativa CBD as we grow the brand across North America. Our partnership will not only allow us to reach a broader audience, but also deliver credibility on our zero-THC promise,” says Dr. Johnny Garcia, CEO and co-Founder of Cativa CBD. “He perfectly embodies Cativa CBD and what we stand for: health, wellness, and a winning spirit.”
Marc Leishman is currently ranked #24 on the Official World Golf Ranking (OWGR) and is highly respected throughout the world of golf. Leishman has won four PGA Tour Events, including the 2012 Travelers Championship, the 2017 Arnold Palmer Invitational, the 2017 BMW Championship and the 2019 CIMB Classic. Mr. Leishman also won the PGA's 2009 Rookie of the Year award, making him the first Australian to win the award. Off the course, Leishman is a dedicated family man passionate about family, wellness and sustaining a healthy life.
“Last year I became very interested in THC-free CBD and its possible health benefits,” says Marc. “When I was introduced to Cativa CBD, I knew I wanted to be a part of their science-based CBD revolution. The brand’s dedication to natural, sustainable products was intriguing, and I felt safe knowing that I didn’t have to worry about THC. Cativa CBD’s future-focused vision is inspiring, and I think their products are helpful to anyone wanting a healthier life.”
The partnership is important because it underscores Cativa CBD’s commitment to the science of wellness. It’s products contain a THC-free CBD isolate derived from the stalks and stems of hemp grown and cultivated in the United States. Cativa CBD partners with leading scientific institutions, including Princeton University and the Zeeh Pharmaceutical Station of the University of Wisconsin School of Pharmacy, which allows it to utilize technologies and formulations not found with other brands. The company’s access to exclusive intellectual property is directly linked to the creation and manufacturing of its products.
For more information about Cativa CBD and its products, please visit www.cativacbd.com.
ABOUT CATIVA CBD
Cativa CBD is a science-based CBD brand committed to creating products that work. Founded in 2018, Cativa CBD is dedicated to using the latest in cutting-edge technology and zero-THC CBD isolates. Cativa CBD was founded with a simple mission: to combine the power of science and the promise of nature to deliver wellness and health. We believe in the untapped potential of CBD to heal the mind and body. And, we are committed to building a limitless future where technology and nature work together. We are passionate about science, sustainability, and promoting human health and the environment. And, we are passionate about you. Cativa CBD is sold via www.CativaCBD.com.
FOOD AND DRUG ADMINISTRATION (FDA) DISCLOSURE
These statements have not been evaluated by the FDA and are not intended to diagnose, treat, or cure any disease.
Cativa CBD does not sell or distribute any products that are in violation of the United States Controlled Substances Act (US CSA). The company sells and distributes hemp-based products. Cannabidiol is a natural constituent of hemp.
Allyson Markey, PR Manager
Back to List Back to List